Technology innovation that brings effective treatment to patients
EClinCloud is a leading AI technology company for clinical research. We build a unified, AI-driven clinical cloud platform and endpoint assessment technology for global pharma and research organizations — using AI predictive models and intelligent data platforms to help improve trial success rates and shorten development cycles, for the benefit of patients.
To become a global leader in AI-driven clinical research
Connected Data
Connecting regulators, sites, sponsors and participants for seamless data interoperability across the research lifecycle.
Better Execution
Supporting more efficient trial delivery, oversight and cross-functional collaboration.
Confident Decisions
Enabling faster, more reliable evidence generation for study teams and sponsors.
Clinical, technology, and commercial leadership
A cross-disciplinary team
Connecting global expertise to drive product innovation for clinical research worldwide.
Leadership
Led by experienced clinical-technology leaders with 15+ years in drug development, connecting clinical, engineering, and global delivery expertise.
Medical experts
Clinicians and medical scientists from leading pharma companies supporting endpoint assessment and scientific services.
Engineering
Engineers from top internet companies with deep expertise in big data, cloud and AI.
Disciplines
Graduates of Peking University, Shanghai Jiao Tong, Sichuan University, the University of Chicago and Northwestern; over a third hold advanced degrees across medicine, bioscience, AI and statistics.
AI innovation journey
Clin Chatbot and the AI Innovation Center
Built Clin Chatbot, a conversational eligibility assistant for study protocols, and established the AI Innovation Center.
Proprietary AI models alongside LLMs
Ran proprietary AI models alongside large language models and developed an in-house OCR model.
LLMs integrated across the platform
Fully integrated large language models to AI-enable the unified platform — from AI algorithms to AI engineering.
New financing round completed
Tens of millions RMB led by Hongfeng Investment, accelerating AI investment.
Launched the embedded AI agent and next-gen IRC platform
Announced at the Shanghai user conference, marking the agent era of clinical research.
250+ organizations, 1,100+ clinical trials
20,000+ global users; solutions deployed across study sites in 10+ countries.
Global footprint
Solutions deployed across study sites in the United States, Canada, the United Kingdom, Spain, Georgia, Poland, Pakistan, Puerto Rico, China, Australia and New Zealand.
Customers & partners
Join us
We're always looking for people across medicine, data, engineering, and AI. See current openings or contact our recruiting team.
Explore careers →